Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
Vanda Pharmaceuticals (Nasdaq: VNDA) has announced it will release its second quarter 2024 financial results on Wednesday, July 31, 2024, after market close. The company will host a conference call at 4:30 PM ET on the same day to discuss the results and other corporate activities. Investors can participate by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) using passcode 1278669.
The call will be broadcast live and archived on Vanda's website. A replay will be available from 8:30 PM ET on July 31 until 11:59 PM ET on August 7, 2024. The replay call-in numbers are 1-800-770-2030 (domestic) and 1-609-800-9909 (international), with the same passcode.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 il mercoledì 31 luglio 2024, dopo la chiusura del mercato. L'azienda ospiterà una call conferenza alle 16:30 ET lo stesso giorno per discutere i risultati e altre attività aziendali. Gli investitori possono partecipare componendo il numero 1-800-715-9871 (nazionale) o 1-646-307-1963 (internazionale) utilizzando il codice di accesso 1278669.
La chiamata sarà trasmessa in diretta e archiviata sul sito web di Vanda. Una registrazione sarà disponibile dalle 20:30 ET del 31 luglio fino alle 23:59 ET del 7 agosto 2024. I numeri per la registrazione della chiamata sono 1-800-770-2030 (nazionale) e 1-609-800-9909 (internazionale), con lo stesso codice di accesso.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el miércoles 31 de julio de 2024, después del cierre del mercado. La empresa llevará a cabo una llamada de conferencia a las 4:30 PM ET el mismo día para discutir los resultados y otras actividades corporativas. Los inversores pueden participar marcando el 1-800-715-9871 (nacional) o el 1-646-307-1963 (internacional) utilizando el código de acceso 1278669.
La llamada será transmitida en vivo y archivada en el sitio web de Vanda. Una grabación estará disponible desde las 8:30 PM ET del 31 de julio hasta las 11:59 PM ET del 7 de agosto de 2024. Los números para acceder a la grabación son 1-800-770-2030 (nacional) y 1-609-800-9909 (internacional), con el mismo código de acceso.
반다 제약(Vanda Pharmaceuticals, Nasdaq: VNDA)은 2024년 2분기 재무 결과를 2024년 7월 31일 수요일, 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 이날 동부 표준시 오후 4:30에 결과 및 기타 회사 활동에 대해 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 투자자들은 1-800-715-9871 (국내) 또는 1-646-307-1963 (국제)로 전화하여 접근 코드 1278669를 사용할 수 있습니다.
콜은 반다의 웹사이트에서 실시간으로 방송되고 저장됩니다. 재생은 7월 31일 오후 8:30부터 2024년 8월 7일 오후 11:59까지 제공됩니다. 재생 전화번호는 1-800-770-2030 (국내)와 1-609-800-9909 (국제)이며, 동일한 접근 코드를 사용합니다.
Vanda Pharmaceuticals (Nasdaq: VNDA) a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le mercredi 31 juillet 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 16h30 ET le même jour pour discuter des résultats et d'autres activités d'entreprise. Les investisseurs peuvent participer en composant le 1-800-715-9871 (national) ou le 1-646-307-1963 (international) en utilisant le code d'accès 1278669.
La conversation sera diffusée en direct et archivée sur le site Web de Vanda. Une rediffusion sera disponible à partir de 20h30 ET le 31 juillet jusqu'à 23h59 ET le 7 août 2024. Les numéros pour accéder à la rediffusion sont 1-800-770-2030 (national) et 1-609-800-9909 (international), avec le même code d'accès.
Vanda Pharmaceuticals (Nasdaq: VNDA) hat angekündigt, dass die Finanzergebnisse für das zweite Quartal 2024 am Mittwoch, den 31. Juli 2024, nach Börsenschluss veröffentlicht werden. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Konferenzschaltung abhalten, um die Ergebnisse und weitere Unternehmensaktivitäten zu besprechen. Investoren können teilnehmen, indem sie 1-800-715-9871 (national) oder 1-646-307-1963 (international) anrufen und den Zugangscode 1278669 verwenden.
Der Anruf wird auf Vandais Webseite live übertragen und archiviert. Eine Wiederholung wird von 20:30 Uhr ET am 31. Juli bis 23:59 Uhr ET am 7. August 2024 verfügbar sein. Die Rückrufnummern sind 1-800-770-2030 (national) und 1-609-800-9909 (international), ebenfalls mit dem gleichen Zugangscode.
- None.
- None.
Conference Call and Webcast to Follow
Vanda will host a conference call at 4:30 PM ET on Wednesday, July 31, 2024, during which management will discuss the second quarter 2024 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 1278669.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, July 31, 2024, beginning at 8:30 PM ET and will be accessible until Wednesday, August 7, 2024, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 1278669.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2024-financial-results-on-july-31-2024-302207567.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When will Vanda Pharmaceuticals (VNDA) release its Q2 2024 financial results?
What time is Vanda Pharmaceuticals' (VNDA) Q2 2024 earnings call scheduled for?
How can investors participate in Vanda Pharmaceuticals' (VNDA) Q2 2024 earnings call?
Until when will the replay of Vanda Pharmaceuticals' (VNDA) Q2 2024 earnings call be available?
